Science & Technology Projects


The OIC Program on Achieving Self Reliance in Vaccine Production (SRVP) In The Islamic World

The Eight Islamic Summit of the OIC held in Tehran in December, 1997 adopted strategies presented by the IDB towards the Preparation of the Ummah for the 21st Century in the areas of education, health, human resources development and intra trade.

 

The IDB formed a Task Force that comprised of experts in the field of Health. The Task Force held two meetings to select the most critical area of intervention under Health. After reviewing several options, the IDB Management selected the subject of "Self-Reliance in Vaccine Production in the Islamic World" considering that vaccination bears a potential positive impact on the health of future generation of the Ummah. Therefore, every member country can either participate in or have the opportunity to benefit from the SRVP program.

 

In October, 1999, a conference on the subject of vaccine production was held in Tehran, where the participants endorsed the IDB Program on Self-Reliance in Vaccine Production (SRVP).

 

Effective worldwide implementation of vaccination during the past decades had been one of the most successful program in communicable diseases prevention, control and eradication. Universal application of the Expanded Program on Immunization (EPI) with the help of WHO, UNICEF and other international organizations has shown the effectiveness of multilateral cooperation in combating preventable diseases with high rate of morbidity and mortality especially in the developing countries.

 

At present, the international community has managed to obtain the understanding of major vaccine producers to increase the affordability of vaccines by recognizing the varying ability of countries to pay the true value of vaccines and hence the tiered pricing of vaccines. It has also been possible to maintain the prices of the 6 basic antigens for infants (BCG, DPT, OPV and measles) at nearly the same level for many years. For other vaccines, some of which are recommended to be added to routine schedule, e.g. Hepatitis-B (HBV) and Hamophitus Influenza b (Hib), vaccine producers are increasing prices in an uncolored way that has negatively affected continuation of vaccination against these diseases in some countries.

 

Except for very few countries of the OIC which are exporting some vaccines, most of the countries are unable to have their vaccines exported mainly due to the fact that they do not satisfy the international quality standards. Such certification is controlled by an independent national control authority exercising the 6 essential functions recommended by the WHO. Vaccine producing countries are required to carry out the required control functions, whereas countries sourcing vaccines from means other than local production need to ensure quality of vaccines by adopting some of these functions.

 

Description of the Program

This program has been established with the following priority objectives:

  1. To produce affordable, good quality and effective vaccines for the Muslim World.
  2. To assure reliable supplies of such vaccines.
  3. To achieve self-reliance in the production of such vaccines in the Islamic World.

 

In order to achieve these objectives the IDB has designed the following strategic framework:

  1. To undertake viability studies of the vaccine production in OIC states in conjunction with their governments, supported by WHO and other agencies.
  2. Identify requirements of vaccine producers to reach the standard of quality assurance required internationally. This could best be made in consultation with interested UN agencies.
  3. Secure the necessary support of national authorities to overcome administrative and logistical constraints facing vaccine production and marketing.
  4. Secure the needed external support (technical, managerial and financial to ensure the quality of produced vaccines and step the level of production to the level required to satisfy the needs of Islamic countries.
  5. Encourage OIC Members to buy vaccines from each other as quality meets international standards.

 

The SRVP program covers two major areas

  1. capacity building of the organizations involved i.e. vaccine producers, National Regulatory Authorities, National Control Laboratories in the respective countries through training and familiarization visits, and
  2. preparation of the technical and economical feasibility studies which can be used as bankable documents to request financing from IDB or any other financing organization.